Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Treponema is a genus of spiral-shaped, motile bacteria known as spirochetes. The most clinically significant species is Treponema pallidum, the causative agent of syphilis and related diseases. Other pathogenic species include T. pallidum pertenue (yaws), T. pallidum endemicum (bejel), and T. carateum (pinta). They are Gram-negative by structure but lacks lipopolysaccharide in its outer membrane and has limited metabolic capabilities, relying on the host for nutrients. Treponema species have no quinone biosynthesis pathways; rely on noncanonical RNF-type redox systems using flavin for electron transport across membranes to generate electrochemical gradients needed for ATP synthesis and motility via flagellar rotation. Visualization requires dark-field or phase contrast microscopy due to its thin structure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Treponema.